Biren Amin - 10 Feb 2022 Form 4 Insider Report for Immuneering Corp (IMRX)

Role
CFO, TREASURER
Signature
/s/ Michael D. Bookman, Attorney-in-Fact for Biren Amin
Issuer symbol
IMRX
Transactions as of
10 Feb 2022
Net transactions value
$0
Form type
4
Filing time
14 Feb 2022, 16:35:27 UTC
Previous filing
04 Aug 2021
Next filing
12 May 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction IMRX Stock Option Award $0 +70,050 $0.000000 70,050 10 Feb 2022 Class A Common Stock 70,050 $9.66 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option vests and becomes exercisable in equal monthly installments over a four-year period commencing on February 1, 2022, and will be fully vested and exercisable on January 1, 2026.